Edgewell Personal Care Company (EPC) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals a decline in key financial metrics like gross margins, operating income, and EPS, with additional currency headwinds and increased expenses. Although management provides optimistic guidance for future recovery, the Q&A section indicates skepticism about margin improvements and the impact of the Fem Care sale. The strategic plan's focus on debt reduction and brand investments doesn't alleviate immediate financial pressures. Given the market cap of ~$2 billion, the negative sentiment is likely to result in a stock price decline of -2% to -8% over the next two weeks.
Key Financial Performance
Organic Net Sales Growth (Q4) 2.5% growth year-over-year. Reasons: Strong performance in international markets and stabilization in North America.
International Organic Net Sales Growth (Q4) 6.9% growth year-over-year. Reasons: Broad-based growth across all segments, driven by volume and price gains.
North America Organic Net Sales Decline (Q4) 0.6% decline year-over-year. Reasons: Growth in Sun Care, Wet Ones, and Grooming offset by declines in Wet Shave.
Adjusted Gross Margin Rate (Q4) Decreased by 330 basis points year-over-year. Reasons: Higher-than-anticipated inventory adjustments, increased trade mix, and unfavorable inflation and tariffs.
Adjusted Operating Income (Q4) $40.3 million (7.5% of net sales), down from $56 million (10.8% of net sales) year-over-year. Reasons: Lower gross margins, FX headwinds, and incremental brand investments.
Adjusted Earnings Per Share (Q4) $0.68, down from $0.72 year-over-year. Reasons: Currency headwinds and lower gross margins.
Adjusted EBITDA (Q4) $59.4 million, down from $78.9 million year-over-year. Reasons: Unfavorable currency impact and lower gross margins.
Net Cash Provided by Operating Activities (Fiscal 2025) $118.4 million, down from $231 million year-over-year. Reasons: Lower earnings and higher working capital build.
Organic Net Sales Decline (Fiscal 2025) 1.3% decline year-over-year. Reasons: Weaker-than-anticipated Sun Care season and increased promotional levels in North America.
Adjusted Gross Margin Rate (Fiscal 2025) Decreased by 110 basis points year-over-year. Reasons: Core inflation, unfavorable mix, and increased promotional levels.
Adjusted Operating Profit (Fiscal 2025) Decreased by $48 million (18%) year-over-year. Reasons: Gross margin rate declines, higher brand marketing investments, and unfavorable currency impact.
Adjusted Operating Margin (Fiscal 2025) 9.9%, down 200 basis points year-over-year. Reasons: Declines in gross margin rate and higher marketing investments.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Billie expansion: Expanded Billie to Australia.
Bulldog premium skin care: Entered premium skin care across Europe.
Schick Progista: Launched in Japan as a premium skin care product.
Cremo range: Broadened in the United States and Europe, driving significant sales growth.
Hawaiian Tropic: Strong growth due to a successful marketing campaign, updated formulations, and on-trend branding.
International market growth: International markets, representing 40% of global sales, delivered strong growth for the fourth consecutive year. Europe generated its third straight year of growth, and Greater China delivered double-digit growth.
North America stabilization: North American markets showed progress with relatively flat sales performance and improvements in consumption and market share.
Supply chain optimization: Delivered over 270 basis points in gross savings in fiscal 2025 and expects 310 basis points in fiscal 2026. Actions include reducing complexity, improving customer service, shortening lead times, and lowering inventory.
North American Wet Shave optimization: Streamlining operations, reducing duplication, and investing in blade excellence and next-generation automation.
Divestiture of Feminine Care business: Key step to transform Edgewell into a more focused, agile, and consumer-driven personal care company.
U.S. commercial transformation: Simplified structure, increased investment in five focus brands, and implemented organizational redesign to improve decision-making and accountability.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Tariffs and Inflation: The company faces significant headwinds from tariffs and inflation, with a net tariff impact of $25 million expected in fiscal 2026. Tariff mitigation efforts have proven challenging due to the inability to source certain materials like steel and aluminum elsewhere.
Foreign Exchange Volatility: Currency fluctuations have negatively impacted earnings, with a $19 million unfavorable impact on adjusted EPS in the fourth quarter of fiscal 2025.
Geopolitical Tensions: Geopolitical uncertainties have stressed the global supply chain and contributed to financial pressures.
North America Business Challenges: The North American market has shown flat or declining sales in key categories like Wet Shave, and the business is undergoing a complex transformation to stabilize and return to growth.
Sun Care Season Performance: Weaker-than-expected sun care seasons in North America and parts of Latin America have negatively impacted financial performance.
Complex U.S. Structure: The U.S. commercial organization was previously too complex, leading to slow decision-making and underinvestment in key capabilities.
Inventory and Trade Adjustments: Higher-than-anticipated year-end inventory adjustments and trade promotions have negatively impacted gross margins.
Consumer Uncertainty: Cautious consumer spending on discretionary items has created a challenging macroeconomic environment.
Feminine Care Business Divestiture: The planned divestiture of the Feminine Care business introduces risks related to stranded overhead costs and transition income.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Fiscal 2026 Organic Net Sales Growth: Expected to range from down 1% to up 2%, with mid-single-digit growth in international markets and flat to slightly down performance in North America.
Gross Margin: Anticipated to increase by 60 basis points year-over-year, driven by 310 basis points of productivity savings and tariff mitigation, partially offset by inflation and negative mix.
Adjusted EBITDA: Projected to be in the range of $290 million to $310 million, approximately flat compared to the prior year at the midpoint.
Adjusted EPS: Expected to range between $2.15 and $2.55, reflecting higher taxes and interest expenses in the first half of the fiscal year.
Free Cash Flow: Anticipated to range from $115 million to $145 million, supported by improvements in working capital.
Capital Allocation: Focus on reducing debt leverage, continuing dividends, and share repurchases to offset dilution. Proceeds from the Feminine Care divestiture will be directed towards debt reduction and investment in core brands and growth initiatives.
Tariff Impact: Net tariff impact after mitigation efforts is expected to be approximately $25 million, with gross impact of $37 million. Mitigation efforts include productivity initiatives and sourcing optimization.
Advertising and Promotional Spending: Planned increase to approximately 11.8% of net sales, up 70 basis points year-over-year, to support brand activation and growth.
Phasing of Financial Performance: Two-thirds of adjusted EBITDA and three-quarters of adjusted EPS are expected in the second half of fiscal 2026, with Q1 adjusted EPS below prior year.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Dividend Payout: Declared $0.15 per share dividend for the fourth quarter.
Share Repurchase Program: Returned approximately $7 million to shareholders via dividend and achieved target of approximately $90 million in share repurchases for fiscal year by the end of Q3.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you discuss the outlook, including underlying category growth assumptions, market share assumptions, and segment results?
A:The '26 plan is balanced and achievable with realistic assumptions. Category growth is expected at a low single-digit rate on average. Market share is expected to hold steady, with 70% of category-country combinations growing or holding share. Sun Care is planned conservatively with low single-digit growth, Shave is flat to slightly growing, and Grooming is leading with growth in line with trends. EPS is expected to be at a loss in Q1 due to margin pressures and tax rate phasing, but stronger performance is anticipated in the second half of the year.
Q:What is the high-level strategy for the portfolio, and is there an intent for M&A given the current environment?
A:The strategy focuses on winning in Shave, Grooming, Sun, and Skin categories, leveraging global scale, IP, and technology. The portfolio is more efficient and focused after the Fem Care sale. Investments are being made in a new automated manufacturing plant for Shave, consolidating four locations into one. M&A will be considered with a high bar for value creation, but the focus remains on reinvesting in brands and improving consumer experience.
Q:Can you provide more details on productivity and gross margin improvements for the year?
A:Productivity efforts have consistently delivered 250 basis points, with expectations of 260 basis points in '26 and 310 basis points with mitigation. Q4 productivity was as expected, but gross margin was impacted by transitory factors like inventory adjustments from plant consolidation and higher trade promotions. Gross margin improvement is expected in the second half of the year, driven by higher sales growth, pricing in international markets, and planogram changes in North America.
Q:How will the proceeds from the Fem Care sale be used, and what is the expected impact on earnings per share?
A:Proceeds from the Fem Care sale, expected to close in early 2026, will be used to pay down debt and strengthen the balance sheet. Approximately 80% of the proceeds will be converted into cash. The focus is on reducing leverage to the 2-3x zone, with M&A considered only if value-creating.
Q:What are the expectations for the Sun and Skin category next year, including inventory levels, competitive environment, and innovation?
A:The Sun and Skin category is expected to grow at low single digits in '26. Inventory levels are clean, and the company is prepared to match promotional intensity if it continues. Hawaiian Tropic is performing well, and a new campaign for Banana Boat is planned. International growth is expected in Europe and Latin America, with a focus on everyday sun protection and enhanced in-store activation.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the specific impact of the Fem Care sale on earnings per share, providing only general comments about debt reduction and financial flexibility. Additionally, while they discussed gross margin improvements, the explanations included vague references to transitory factors and lacked detailed numerical evidence to fully establish confidence in the recovery plan.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
America opportunity
America part
America recovery
America stage
America value
Asia
Care statement
Feminine Care
Shave Sun
awareness product
brand awareness
brand market
challenge
core brand
customer
decision
detail
digit market
duplication
engagement
exchange
foundation
generation
item
label
market sale
marketing
mitigation effort
outlook plan
portfolio structure
position
productivity efficiency
review
road map
sale share
shave
skin care
strength area
sun care
talent
EPC Transcript
Edgewell Personal Care Company (EPC) Q2 2026 Earnings Call Transcript
Positive5-6
The earnings call summary indicates strong financial performance with increased revenue, gross margin, and net income, alongside positive EPS growth. Strategic initiatives include product launches and brand investments, highlighting innovation and market expansion. Despite risks like commodity costs and inflation, the company's focus on cost mitigation and productivity efficiency is promising. Plans for shareholder returns and a robust free cash flow further support a positive outlook. Given the market cap, a positive sentiment is anticipated, leading to a stock price increase in the 2% to 8% range.
Edgewell Personal Care Company (EPC) Q1 2026 Earnings Call Transcript
Unknown2-9
The earnings call reveals several concerns: declining sales in key categories, decreased gross margins, and increased operating cash usage. The Q&A highlights uncertainties, such as the impact of the Fem Care divestiture and vague guidance for future growth. Despite some positive aspects, like Sun Care growth and strategic focus, the overall sentiment is negative due to weak financial performance and lack of clear future guidance, likely resulting in a stock price decline.
Edgewell Personal Care Company (EPC) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Neutral12-2
Edgewell Personal Care Company (EPC) Q4 2025 Earnings Call Transcript
Unknown11-13
The earnings call reveals a decline in key financial metrics like gross margins, operating income, and EPS, with additional currency headwinds and increased expenses. Although management provides optimistic guidance for future recovery, the Q&A section indicates skepticism about margin improvements and the impact of the Fem Care sale. The strategic plan's focus on debt reduction and brand investments doesn't alleviate immediate financial pressures. Given the market cap of ~$2 billion, the negative sentiment is likely to result in a stock price decline of -2% to -8% over the next two weeks.
EPC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
